Core C: B Cell Core
核心C:B细胞核心
基本信息
- 批准号:10731279
- 负责人:
- 金额:$ 26.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAntibodiesAntibody AvidityAntibody RepertoireAntibody ResponseAntigensAutologousAvidityB-Cell Antigen ReceptorB-Cell DevelopmentB-LymphocytesB-cell receptor repertoire sequencingBar CodesBindingBiological AssayBiometryBone MarrowCell LineageCellsCollaborationsComputer AnalysisDataDevelopmentDoseEngineeringEnvironmentEnzyme-Linked Immunosorbent AssayEpitopesEvolutionFlow CytometryFutureGenerationsGoalsHIVHIV vaccineHIV-1ImmuneImmune responseImmune systemImmunityImmunizationInfantInfectionLaboratoriesLeadLifeLymphoid TissueMacacaMacaca mulattaMediatingMedicineMessenger RNAMolecular ProfilingMonoclonal AntibodiesNatural ImmunityNaturePhenotypePlasmaPlasma CellsPredispositionProcessProteomicsRegimenReproducibilityResourcesRunningSerumSortingSpecificitySurface Plasmon ResonanceTechnologyTimeVaccinatedVaccinationVaccine DesignVaccineeVaccinesVirusWorkautoreactivityexperiencegenetic signaturegenomic platforminnovationlymph nodesmicrobialmicrobiomemicroorganism interactionneutralizing antibodynext generation sequencingnonhuman primateprogramsresponsesingle-cell RNA sequencingtime usetooltranscriptomicstransmission processvaccine evaluationvaccine immunogenicityvaccine strategy
项目摘要
ABSTRACT – B Cell Core
Early development of bNAbs in infants suggest potentially distinct mechanisms in the generation of antibody
breadth due to the highly dynamic nature of the infant immune system. Moreover, we have observed elicitation
of bNAb precursors in infant rhesus monkeys with germline-targeting HIV Env SOSIP immunization. We
hypothesize that induction of bnAb precursor B cells using germline-targeting HIV Env SOSIP immunogens
requires specific innate and microbial interactions which are modifiable to enhance future HIV vaccine strategies,
particularly in early life. In this context, we propose a B Cell Core that will perform in-depth quantification and
characterization of the plasma and B cell responses after BG505 SOSIP GT1.1 immunizations in infant
macaques over time through i) the quantification of the functional activity, avidity and target epitope of polyclonal
plasma antibody responses (Aim 1) and ii) single cell RNA sequencing of antigen-specific B cell analysis (Aim
2) to evaluate the evolution of vaccine-elicited HIV bNAb precursors and relate these responses to innate
immunity (Project 1) and microbial interactions (Project 2). To accomplish this goal, the B Cell Core will draw
on the extensive experience and unique resources in antibody and B cell response characterization of the B Cell
Core Leader Dr. Marit van Gils at Amsterdam UMC and Dr. Sallie Permar at Weill Cornell Medicine.
摘要:B细胞核心
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristina De Paris其他文献
Kristina De Paris的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kristina De Paris', 18)}}的其他基金
Project 1: The impact of innate immune responses on the development of broadly neutralizing antibodies by vaccination
项目 1:先天免疫反应对通过疫苗接种产生广泛中和抗体的影响
- 批准号:
10731281 - 财政年份:2023
- 资助金额:
$ 26.78万 - 项目类别:
Project 2: Microbial determinants of HIV broadly-neutralizing antibody precursor induction in infants
项目2:婴儿中HIV广泛中和抗体前体诱导的微生物决定因素
- 批准号:
10731282 - 财政年份:2023
- 资助金额:
$ 26.78万 - 项目类别:
Determinants of HIV broadly-neutralizing antibody precursor induction in infants
婴儿中 HIV 广泛中和抗体前体诱导的决定因素
- 批准号:
10731276 - 财政年份:2023
- 资助金额:
$ 26.78万 - 项目类别:
Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia
X 连锁无丙种球蛋白血症患者中疫苗诱导的 SARS-CoV-2 特异性 T 细胞反应
- 批准号:
10593523 - 财政年份:2023
- 资助金额:
$ 26.78万 - 项目类别:
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
SARS-CoV-2 稳定预灌注 Spike 蛋白疫苗在幼年恒河猴中的免疫原性和功效
- 批准号:
10223634 - 财政年份:2020
- 资助金额:
$ 26.78万 - 项目类别:
Subingual-parenteral Vaccination to Prevent Oral HIV Transmission in Infants
舌下注射疫苗预防婴儿经口艾滋病毒传播
- 批准号:
10172886 - 财政年份:2018
- 资助金额:
$ 26.78万 - 项目类别:
Subingual-parenteral Vaccination to Prevent Oral HIV Transmission in Infants
舌下注射疫苗预防婴儿经口艾滋病毒传播
- 批准号:
10425465 - 财政年份:2018
- 资助金额:
$ 26.78万 - 项目类别:
The Pros and Cons of Trained Immunity Induced by Vaccines for Tuberculosis Prevention
结核病预防疫苗诱导的训练免疫的利与弊
- 批准号:
9207318 - 财政年份:2016
- 资助金额:
$ 26.78万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 26.78万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 26.78万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 26.78万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 26.78万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 26.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 26.78万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 26.78万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 26.78万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 26.78万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 26.78万 - 项目类别: